HEADER TRANSFERASE 03-OCT-16 5TIX TITLE SCHISTOSOMA HAEMATOBIUM (BLOOD FLUKE) SULFOTRANSFERASE/R-OXAMNIQUINE TITLE 2 COMPLEX COMPND MOL_ID: 1; COMPND 2 MOLECULE: SULFOTRANSFERASE; COMPND 3 CHAIN: A, B; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SCHISTOSOMA HAEMATOBIUM; SOURCE 3 ORGANISM_COMMON: BLOOD FLUKE; SOURCE 4 ORGANISM_TAXID: 6185; SOURCE 5 GENE: MS3_07706; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21 PLYSS; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID KEYWDS SULFOTRANSFERASE, PARASITE, HELMINTH, OXAMNIQUINE, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR A.B.TAYLOR,P.J.HART REVDAT 4 04-OCT-23 5TIX 1 REMARK REVDAT 3 19-JUL-17 5TIX 1 JRNL REVDAT 2 07-JUN-17 5TIX 1 JRNL REVDAT 1 31-MAY-17 5TIX 0 JRNL AUTH A.B.TAYLOR,K.M.ROBERTS,X.CAO,N.E.CLARK,S.P.HOLLOWAY, JRNL AUTH 2 E.DONATI,C.M.POLCARO,L.PICA-MATTOCCIA,R.S.TARPLEY, JRNL AUTH 3 S.F.MCHARDY,D.CIOLI,P.T.LOVERDE,P.F.FITZPATRICK,P.J.HART JRNL TITL STRUCTURAL AND ENZYMATIC INSIGHTS INTO SPECIES-SPECIFIC JRNL TITL 2 RESISTANCE TO SCHISTOSOME PARASITE DRUG THERAPY. JRNL REF J. BIOL. CHEM. V. 292 11154 2017 JRNL REFN ESSN 1083-351X JRNL PMID 28536265 JRNL DOI 10.1074/JBC.M116.766527 REMARK 2 REMARK 2 RESOLUTION. 1.78 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (1.10_2155: ???) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.78 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 39.00 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.970 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.9 REMARK 3 NUMBER OF REFLECTIONS : 50287 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.190 REMARK 3 R VALUE (WORKING SET) : 0.188 REMARK 3 FREE R VALUE : 0.230 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 3.980 REMARK 3 FREE R VALUE TEST SET COUNT : 1999 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 39.0097 - 4.2883 0.97 3626 150 0.1716 0.1992 REMARK 3 2 4.2883 - 3.4044 0.99 3523 146 0.1555 0.1911 REMARK 3 3 3.4044 - 2.9742 0.99 3497 144 0.1746 0.2302 REMARK 3 4 2.9742 - 2.7024 0.99 3448 143 0.1963 0.2210 REMARK 3 5 2.7024 - 2.5087 0.99 3473 144 0.1981 0.2432 REMARK 3 6 2.5087 - 2.3608 0.99 3451 143 0.1865 0.2492 REMARK 3 7 2.3608 - 2.2426 0.99 3449 143 0.1916 0.2200 REMARK 3 8 2.2426 - 2.1450 1.00 3429 141 0.1912 0.2677 REMARK 3 9 2.1450 - 2.0624 0.99 3417 142 0.2081 0.2557 REMARK 3 10 2.0624 - 1.9913 0.99 3448 142 0.2157 0.2546 REMARK 3 11 1.9913 - 1.9290 0.99 3414 142 0.2307 0.3250 REMARK 3 12 1.9290 - 1.8739 0.99 3405 141 0.2474 0.2761 REMARK 3 13 1.8739 - 1.8245 0.99 3367 140 0.2523 0.2990 REMARK 3 14 1.8245 - 1.7800 0.98 3341 138 0.2642 0.3155 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.20 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.210 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 23.870 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 22.90 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 29.60 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.003 4246 REMARK 3 ANGLE : 0.608 5772 REMARK 3 CHIRALITY : 0.052 638 REMARK 3 PLANARITY : 0.003 718 REMARK 3 DIHEDRAL : 14.587 1608 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5TIX COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 04-OCT-16. REMARK 100 THE DEPOSITION ID IS D_1000224317. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-SEP-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU MICROMAX-007 HF REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54178 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS HTC REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 50370 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.780 REMARK 200 RESOLUTION RANGE LOW (A) : 46.230 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 200 DATA REDUNDANCY : 4.500 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.08600 REMARK 200 FOR THE DATA SET : 13.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.78 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.88 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.4 REMARK 200 DATA REDUNDANCY IN SHELL : 4.60 REMARK 200 R MERGE FOR SHELL (I) : 0.64500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 5TIV REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.68 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.22 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.06 M (MAGNESIUM CHLORIDE; CALCIUM REMARK 280 CHLORIDE), 0.1 M (TRIS; BICINE) PH 8.5, 37.5% (MPD; PEG 1000; REMARK 280 PEG 3350), VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 295K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 25.83800 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 69.34750 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 36.31350 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 69.34750 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 25.83800 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 36.31350 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 14 REMARK 465 ALA A 15 REMARK 465 MET A 16 REMARK 465 SER A 17 REMARK 465 THR A 18 REMARK 465 THR A 19 REMARK 465 SER A 20 REMARK 465 GLY B 14 REMARK 465 ALA B 15 REMARK 465 MET B 16 REMARK 465 SER B 17 REMARK 465 THR B 18 REMARK 465 THR B 19 REMARK 465 SER B 20 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 59 -36.28 -130.83 REMARK 500 ASP A 100 173.26 71.03 REMARK 500 ASN A 237 40.80 75.48 REMARK 500 LEU A 265 -59.72 -120.67 REMARK 500 LYS B 59 -36.43 -134.35 REMARK 500 ASP B 100 171.76 69.89 REMARK 500 ASP B 159 -159.46 -129.56 REMARK 500 ASN B 237 42.91 73.44 REMARK 500 LEU B 265 -54.15 -127.91 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue A3P A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue OQR A 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue A3P B 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue OQR B 302 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5TIV RELATED DB: PDB REMARK 900 RELATED ID: 5TIW RELATED DB: PDB REMARK 900 RELATED ID: 5TIY RELATED DB: PDB REMARK 900 RELATED ID: 5TIZ RELATED DB: PDB DBREF1 5TIX A 17 266 UNP A0A094ZWQ2_SCHHA DBREF2 5TIX A A0A094ZWQ2 17 266 DBREF1 5TIX B 17 266 UNP A0A094ZWQ2_SCHHA DBREF2 5TIX B A0A094ZWQ2 17 266 SEQADV 5TIX GLY A 14 UNP A0A094ZWQ EXPRESSION TAG SEQADV 5TIX ALA A 15 UNP A0A094ZWQ EXPRESSION TAG SEQADV 5TIX MET A 16 UNP A0A094ZWQ EXPRESSION TAG SEQADV 5TIX GLY B 14 UNP A0A094ZWQ EXPRESSION TAG SEQADV 5TIX ALA B 15 UNP A0A094ZWQ EXPRESSION TAG SEQADV 5TIX MET B 16 UNP A0A094ZWQ EXPRESSION TAG SEQRES 1 A 253 GLY ALA MET SER THR THR SER THR THR ILE GLN VAL ILE SEQRES 2 A 253 GLY ALA GLY LEU PRO ARG THR GLY THR ASN SER MET LYS SEQRES 3 A 253 LYS ALA LEU GLU ILE ILE TYR SER LYS PRO CYS TYR HIS SEQRES 4 A 253 MET TYR GLU ILE ILE PHE LYS LYS GLN SER ASP ILE SER SEQRES 5 A 253 ILE TRP GLN GLN LEU ILE ASP GLU THR HIS LYS THR THR SEQRES 6 A 253 SER ASP LYS ARG LYS ILE TYR ASN GLY LEU ASN GLU LEU SEQRES 7 A 253 LEU ASN GLY TYR ILE ALA THR THR ASP LEU PRO SER CYS SEQRES 8 A 253 SER PHE TYR LYS GLU LEU MET THR MET TYR PRO ASN ALA SEQRES 9 A 253 LYS VAL LEU LEU THR ILE ARG ASP LYS TYR ASP TRP LEU SEQRES 10 A 253 TYR SER LEU ARG LYS VAL VAL LEU PRO LYS SER THR ASP SEQRES 11 A 253 PRO TRP LYS LEU LYS ILE GLU GLU GLY ASP GLN VAL LEU SEQRES 12 A 253 GLY ILE ASP SER ASN PHE TYR LYS MET SER GLU ASP SER SEQRES 13 A 253 LEU LYS PHE ALA PHE GLN LYS ASN HIS ILE ASN LEU ASP SEQRES 14 A 253 ASP ASP GLU ILE LEU LEU GLU CYS TYR ASP GLU TYR ASN SEQRES 15 A 253 ARG LEU VAL GLN GLU ILE VAL PRO PRO GLU ARG LEU LEU SEQRES 16 A 253 ILE HIS HIS LEU GLY ASP GLY TRP GLU SER LEU CYS GLN SEQRES 17 A 253 PHE LEU ASN VAL ASP ILE PRO ASN GLY ILE SER TYR PRO SEQRES 18 A 253 CYS ALA ASN SER HIS HIS GLN MET THR GLN LEU THR GLU SEQRES 19 A 253 GLN LEU ILE LYS HIS LYS SER LEU ASP ASP ILE ILE HIS SEQRES 20 A 253 MET PHE PRO GLY LEU ILE SEQRES 1 B 253 GLY ALA MET SER THR THR SER THR THR ILE GLN VAL ILE SEQRES 2 B 253 GLY ALA GLY LEU PRO ARG THR GLY THR ASN SER MET LYS SEQRES 3 B 253 LYS ALA LEU GLU ILE ILE TYR SER LYS PRO CYS TYR HIS SEQRES 4 B 253 MET TYR GLU ILE ILE PHE LYS LYS GLN SER ASP ILE SER SEQRES 5 B 253 ILE TRP GLN GLN LEU ILE ASP GLU THR HIS LYS THR THR SEQRES 6 B 253 SER ASP LYS ARG LYS ILE TYR ASN GLY LEU ASN GLU LEU SEQRES 7 B 253 LEU ASN GLY TYR ILE ALA THR THR ASP LEU PRO SER CYS SEQRES 8 B 253 SER PHE TYR LYS GLU LEU MET THR MET TYR PRO ASN ALA SEQRES 9 B 253 LYS VAL LEU LEU THR ILE ARG ASP LYS TYR ASP TRP LEU SEQRES 10 B 253 TYR SER LEU ARG LYS VAL VAL LEU PRO LYS SER THR ASP SEQRES 11 B 253 PRO TRP LYS LEU LYS ILE GLU GLU GLY ASP GLN VAL LEU SEQRES 12 B 253 GLY ILE ASP SER ASN PHE TYR LYS MET SER GLU ASP SER SEQRES 13 B 253 LEU LYS PHE ALA PHE GLN LYS ASN HIS ILE ASN LEU ASP SEQRES 14 B 253 ASP ASP GLU ILE LEU LEU GLU CYS TYR ASP GLU TYR ASN SEQRES 15 B 253 ARG LEU VAL GLN GLU ILE VAL PRO PRO GLU ARG LEU LEU SEQRES 16 B 253 ILE HIS HIS LEU GLY ASP GLY TRP GLU SER LEU CYS GLN SEQRES 17 B 253 PHE LEU ASN VAL ASP ILE PRO ASN GLY ILE SER TYR PRO SEQRES 18 B 253 CYS ALA ASN SER HIS HIS GLN MET THR GLN LEU THR GLU SEQRES 19 B 253 GLN LEU ILE LYS HIS LYS SER LEU ASP ASP ILE ILE HIS SEQRES 20 B 253 MET PHE PRO GLY LEU ILE HET A3P A 301 27 HET OQR A 302 20 HET A3P B 301 27 HET OQR B 302 20 HETNAM A3P ADENOSINE-3'-5'-DIPHOSPHATE HETNAM OQR {(2R)-7-NITRO-2-[(PROPAN-2-YLAMINO)METHYL]-1,2,3,4- HETNAM 2 OQR TETRAHYDROQUINOLIN-6-YL}METHANOL HETSYN OQR OXAMNIQUINE FORMUL 3 A3P 2(C10 H15 N5 O10 P2) FORMUL 4 OQR 2(C14 H21 N3 O3) FORMUL 7 HOH *432(H2 O) HELIX 1 AA1 GLY A 34 SER A 47 1 14 HELIX 2 AA2 HIS A 52 LYS A 59 1 8 HELIX 3 AA3 SER A 62 LYS A 76 1 15 HELIX 4 AA4 ASP A 80 LEU A 92 1 13 HELIX 5 AA5 PRO A 102 SER A 105 5 4 HELIX 6 AA6 PHE A 106 TYR A 114 1 9 HELIX 7 AA7 ASP A 125 VAL A 137 1 13 HELIX 8 AA8 PRO A 144 LEU A 156 1 13 HELIX 9 AA9 ASP A 159 PHE A 174 1 16 HELIX 10 AB1 ASP A 183 VAL A 202 1 20 HELIX 11 AB2 PRO A 203 GLU A 205 5 3 HELIX 12 AB3 GLY A 215 ASN A 224 1 10 HELIX 13 AB4 SER A 238 LYS A 253 1 16 HELIX 14 AB5 ILE A 258 PHE A 262 5 5 HELIX 15 AB6 GLY B 34 SER B 47 1 14 HELIX 16 AB7 HIS B 52 LYS B 59 1 8 HELIX 17 AB8 SER B 62 HIS B 75 1 14 HELIX 18 AB9 ASP B 80 LEU B 92 1 13 HELIX 19 AC1 PRO B 102 SER B 105 5 4 HELIX 20 AC2 PHE B 106 TYR B 114 1 9 HELIX 21 AC3 ASP B 125 VAL B 137 1 13 HELIX 22 AC4 PRO B 144 LEU B 156 1 13 HELIX 23 AC5 ASP B 159 PHE B 174 1 16 HELIX 24 AC6 ASP B 183 VAL B 202 1 20 HELIX 25 AC7 PRO B 203 GLU B 205 5 3 HELIX 26 AC8 GLY B 215 ASN B 224 1 10 HELIX 27 AC9 SER B 238 LYS B 253 1 16 HELIX 28 AD1 ILE B 258 PHE B 262 5 5 SHEET 1 AA1 5 CYS A 50 TYR A 51 0 SHEET 2 AA1 5 ALA A 97 THR A 98 1 O ALA A 97 N TYR A 51 SHEET 3 AA1 5 VAL A 25 GLY A 27 1 N GLY A 27 O THR A 98 SHEET 4 AA1 5 LYS A 118 ILE A 123 1 O LYS A 118 N ILE A 26 SHEET 5 AA1 5 LEU A 207 HIS A 211 1 O LEU A 208 N LEU A 121 SHEET 1 AA2 5 CYS B 50 TYR B 51 0 SHEET 2 AA2 5 ALA B 97 THR B 98 1 O ALA B 97 N TYR B 51 SHEET 3 AA2 5 VAL B 25 GLY B 27 1 N GLY B 27 O THR B 98 SHEET 4 AA2 5 LYS B 118 ILE B 123 1 O LEU B 120 N ILE B 26 SHEET 5 AA2 5 LEU B 207 HIS B 211 1 O HIS B 210 N LEU B 121 CISPEP 1 LEU A 101 PRO A 102 0 -1.65 CISPEP 2 LEU B 101 PRO B 102 0 -3.29 SITE 1 AC1 24 ARG A 32 THR A 33 GLY A 34 THR A 35 SITE 2 AC1 24 ASN A 36 SER A 37 ARG A 124 SER A 132 SITE 3 AC1 24 LEU A 212 PRO A 234 CYS A 235 ALA A 236 SITE 4 AC1 24 ASN A 237 SER A 238 HIS A 239 HOH A 454 SITE 5 AC1 24 HOH A 471 HOH A 489 HOH A 490 HOH A 508 SITE 6 AC1 24 HOH A 522 HOH A 525 HOH A 549 HOH A 565 SITE 1 AC2 9 MET A 53 LEU A 101 VAL A 137 LEU A 138 SITE 2 AC2 9 ASP A 153 PHE A 162 TYR A 163 SER A 166 SITE 3 AC2 9 GLU A 167 SITE 1 AC3 22 ARG B 32 THR B 33 GLY B 34 THR B 35 SITE 2 AC3 22 ASN B 36 SER B 37 ARG B 124 SER B 132 SITE 3 AC3 22 LEU B 212 PRO B 234 CYS B 235 ALA B 236 SITE 4 AC3 22 ASN B 237 SER B 238 HIS B 239 HOH B 463 SITE 5 AC3 22 HOH B 469 HOH B 472 HOH B 485 HOH B 506 SITE 6 AC3 22 HOH B 526 HOH B 534 SITE 1 AC4 8 LEU B 101 VAL B 137 LEU B 138 ASP B 153 SITE 2 AC4 8 PHE B 162 TYR B 163 SER B 166 GLU B 167 CRYST1 51.676 72.627 138.695 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019351 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013769 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007210 0.00000